Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 96 results for "Tecfidera"

Hedge fund loses challenge of patent for Biogen's MS drug
Boston Globe

Hedge fund loses challenge of patent for Biogen's MS drug

Biogen Inc. fended off a closely followed patent challenge to its blockbuster multiple scleroris drug Tecfidera, dealing another setback to Texas hedge fund manager Kyle Bass and his attempts to invalidate key intellectual property rights of leading ... Boston Globe, 1 month ago

Biogen profit rises 30% on higher Tecfidera sales

The US biotechnology company's revenue rose about 7 percent to $2.59 billion. Biogen Inc reported a 30 percent rise in quarterly profit, driven by strong sales of its top-selling oral multiple sclerosis drug, Tecfidera. Net profit attributable to Biogen rose ...
 Economic Times2 months ago
Sys-Con Media

Biogen's Tecfidera And Other Orals Benefit As Increasingly Risk-Tolerant Neurologists Seek To Arrest Multiple Sclerosis (MS) Progression Sooner

_ Other key insights from the research While oral therapies such as Biogen's Tecfidera and Novartis' Gilenya are now being used in newly diagnosed and first switch patients, the fate of new non-oral agents has been mixed. Biogen's Plegridy, is the ...
 Sys-Con Media1 month ago
Monthly Prescribing Reference

Tecfidera: Positive Data from Three Phase 3 Studies

Biogen will present new data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Spain (October 710), showing that Tecfidera (dimethyl fumarate) significantly reduced multiple ...
 Monthly Prescribing Reference20 hours ago New data shows sustained efficacy of Tecfidera in RRMS  European Pharmaceutical Review1 day ago
National Law Review

Patent Trial and Appeal Board Boots Bass Tecfidera IPR On The Merits

On September 2, 2015, the USPTO Patent Trial and Appeal Board (PTAB) denied institution of another Inter Partes Review brought by Kyle Bass,the Coalition for Affordable Drugs, and other related entities. In denying the Tecfidera IPR petition, The ...
 National Law Review4 weeks ago Kyle Bass big new hedge fund strategy isn't going so well  Business Insider UK1 month ago Kyle Bass' big, new hedge fund strategy isn't going so well  Yahoo! Finance1 month ago

Biogen Lowers Its Full-Year 2015 Outlook in 2Q15

Biogen's blockbuster drug Tecfidera registered much-lower-than-expected revenue growth, resulting in low full-year
 Yahoo! Canada2 months ago

Elite Investors Disagree With Saudi Prince On Twitter, Like This Trending Biotech

Shares of Twitter Inc (NYSE: TWTR ) and Biogen Inc (NASDAQ: BIIB ) are up by 4% and 2.4% respectively in afternoon trading, as investors become more optimistic about the two companies prospects. An SEC filing showed that Prince Alwaleed bin Talal ...
 InsiderMonkey.com1 day ago Adriana Karaboutis the EVP Tech. and Bus. Solutions of Biogen Inc (NASDAQ:BIIB) Unloaded 269 Shares  Octafinance1 day ago Biogen: BIIB Stock May Be a Rare Biotech Value  InvestorPlace.com2 weeks ago Is Biogen Inc (BIIB) Recovering? Jefferies Weighs In  Bidness Etc4 weeks ago

Stocks May Open Higher Amid Strength Overseas - U.S. Commentary

Stocks are likely to move back to the upside in early trading on Wednesday after experiencing some profit taking in the previous session. The major index futures are pointing to a higher open for the markets, with the Dow futures up by 110 points. ...
 RTTNews.com1 day ago
Motley Fool

3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical

Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in March ...
 Motley Fool1 day ago Biotechs Battered: Comments On All Six Major Biotech Stocks  Seeking Alpha1 week ago

Early movers: YUM, BIIB, BUD & more

Traders work on the floor of the New York Stock Exchange. Check out which companies are making headlines before the bell : Constellation Brands — The spirits maker earned an adjusted $1.56 per ...
 CNBC1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Tecfidera
Get updated on latest news & your favorite topics right in your inbox!
More     Less